Search terms
Amsterdam, The Netherlands - Royal Philips (NYSE: PHG, AEX: PHIA) today reported the transaction details related to the repurchases of its own common shares made in the period from December 30, 2016 up to and including January 5, 2017.
These repurchases were made under the repurchase program to cover long term incentive and employee share purchase plans. Further details can be found in the table below and via this link.
| Date | Total number of repurchased shares | Weighted average purchased price (EUR) |
| December 30, 2016 | 100,000 | 28.8861 |
| January 2, 2017 | 10,000 | 29.1906 |
| January 3, 2017 | 200,000 | 28.9946 |
| January 4, 2017 | 150,000 | 28.4877 |
| January 5, 2017 | 30,000 | 28.3982 |
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2015 sales of EUR 16.8 billion and employs approximately 70,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter. Read MoreRead Less
Philips Group Press Office
Tel: +31 6 1521 3446
Philips Investor Relations
Tel: +31 20 59 77055
February 26, 2019
